Mehran Sugar Mills Limited (MRNS)
Feb 11, 2025 - MRNS was delisted (reason: acquired by Immedica)
0.5500
+0.0010 (0.09%)
Inactive · Last trade price on Feb 11, 2025

Marinus Pharmaceuticals Revenue

Marinus Pharmaceuticals had revenue of 4.13B PKR in the quarter ending June 30, 2025, a decrease of -3.32%. This brings the company's revenue in the last twelve months to 13.95B, up 13.80% year-over-year. In the fiscal year ending September 30, 2024, Marinus Pharmaceuticals had annual revenue of 10.99B with 0.05% growth.

Revenue (ttm)
13.95B PKR
Revenue Growth
+13.80%
P/S Ratio
0.38
Revenue / Employee
50,183,723 PKR
Employees
278
Market Cap
18.74M USD

Revenue Chart

* This company reports financials in PKR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202410.99B5.34M0.05%
Sep 30, 202310.98B4.09B59.23%
Sep 30, 20226.90B834.49M13.76%
Sep 30, 20216.06B-361.14M-5.62%
Sep 30, 20206.42B1.11B20.95%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition